![](/img/cover-not-exists.png)
Preclinical validation of 111 In-girentuximab-F(ab′) 2 as a tracer to image hypoxia related marker CAIX expression in head and neck cancer xenografts
Huizing, Fokko J., Hoeben, Bianca A.W., Franssen, Gerben, Lok, Jasper, Heskamp, Sandra, Oosterwijk, Egbert, Boerman, Otto C., Bussink, JohanLanguage:
english
Journal:
Radiotherapy and Oncology
DOI:
10.1016/j.radonc.2017.07.025
Date:
August, 2017
File:
PDF, 1018 KB
english, 2017